| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10911162 | Lung Cancer | 2014 | 7 Pages |
Abstract
These findings suggest that the pharmacokinetics and metabolism of erlotinib are related to skin toxicity and may support further studies where erlotinib dosing is tailored according to pharmacokinetic parameters.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Marcello Tiseo, Roberta Andreoli, Francesco Gelsomino, Paola Mozzoni, Cinzia Azzoni, Marco Bartolotti, Beatrice Bortesi, Matteo Goldoni, Enrico Maria Silini, Giuseppe De Palma, Antonio Mutti, Andrea Ardizzoni,